Logo image of HSII

HEIDRICK & STRUGGLES INTL (HSII) Stock Fundamental Analysis

NASDAQ:HSII - Nasdaq - US4228191023 - Common Stock - Currency: USD

41.41  -0.82 (-1.94%)

After market: 41.41 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to HSII. HSII was compared to 82 industry peers in the Professional Services industry. Both the profitability and the financial health of HSII get a neutral evaluation. Nothing too spectacular is happening here. HSII is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

HSII had positive earnings in the past year.
In the past year HSII had a positive cash flow from operations.
HSII had positive earnings in 4 of the past 5 years.
Of the past 5 years HSII 4 years had a positive operating cash flow.
HSII Yearly Net Income VS EBIT VS OCF VS FCFHSII Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M

1.2 Ratios

The Return On Assets of HSII (3.37%) is comparable to the rest of the industry.
HSII has a Return On Equity (7.98%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 6.62%, HSII is in line with its industry, outperforming 49.37% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for HSII is below the industry average of 13.65%.
Industry RankSector Rank
ROA 3.37%
ROE 7.98%
ROIC 6.62%
ROA(3y)6.03%
ROA(5y)3.77%
ROE(3y)17.58%
ROE(5y)10.76%
ROIC(3y)10.58%
ROIC(5y)9.5%
HSII Yearly ROA, ROE, ROICHSII Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20

1.3 Margins

Looking at the Profit Margin, with a value of 3.53%, HSII is in line with its industry, outperforming 50.63% of the companies in the same industry.
HSII's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 6.98%, HSII perfoms like the industry average, outperforming 56.96% of the companies in the same industry.
HSII's Operating Margin has declined in the last couple of years.
HSII has a better Gross Margin (87.64%) than 94.94% of its industry peers.
HSII's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.98%
PM (TTM) 3.53%
GM 87.64%
OM growth 3Y0.09%
OM growth 5Y-3.26%
PM growth 3YN/A
PM growth 5Y-4.85%
GM growth 3Y-3.72%
GM growth 5Y-1.96%
HSII Yearly Profit, Operating, Gross MarginsHSII Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

6

2. Health

2.1 Basic Checks

HSII has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
HSII has more shares outstanding than it did 1 year ago.
HSII has more shares outstanding than it did 5 years ago.
HSII has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
HSII Yearly Shares OutstandingHSII Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
HSII Yearly Total Debt VS Total AssetsHSII Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

HSII has an Altman-Z score of 2.53. This is not the best score and indicates that HSII is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.53, HSII is in line with its industry, outperforming 41.77% of the companies in the same industry.
There is no outstanding debt for HSII. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.53
ROIC/WACC0.73
WACC9.06%
HSII Yearly LT Debt VS Equity VS FCFHSII Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.73 indicates that HSII should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.73, HSII is in the better half of the industry, outperforming 68.35% of the companies in the same industry.
A Quick Ratio of 1.73 indicates that HSII should not have too much problems paying its short term obligations.
HSII's Quick ratio of 1.73 is fine compared to the rest of the industry. HSII outperforms 68.35% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.73
HSII Yearly Current Assets VS Current LiabilitesHSII Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

3

3. Growth

3.1 Past

HSII shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.33%.
HSII shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.89% yearly.
HSII shows a small growth in Revenue. In the last year, the Revenue has grown by 6.81%.
HSII shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.19% yearly.
EPS 1Y (TTM)-7.33%
EPS 3Y17.99%
EPS 5Y2.89%
EPS Q2Q%-1.37%
Revenue 1Y (TTM)6.81%
Revenue growth 3Y18.27%
Revenue growth 5Y7.19%
Sales Q2Q%7.47%

3.2 Future

HSII is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.61% yearly.
Based on estimates for the next years, HSII will show a small growth in Revenue. The Revenue will grow by 4.32% on average per year.
EPS Next Y-6.9%
EPS Next 2Y0.25%
EPS Next 3Y5.61%
EPS Next 5YN/A
Revenue Next Year6.33%
Revenue Next 2Y4.69%
Revenue Next 3Y4.32%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HSII Yearly Revenue VS EstimatesHSII Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
HSII Yearly EPS VS EstimatesHSII Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 14.90, the valuation of HSII can be described as correct.
68.35% of the companies in the same industry are more expensive than HSII, based on the Price/Earnings ratio.
HSII's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 29.63.
A Price/Forward Earnings ratio of 14.02 indicates a correct valuation of HSII.
Based on the Price/Forward Earnings ratio, HSII is valued a bit cheaper than 68.35% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of HSII to the average of the S&P500 Index (22.68), we can say HSII is valued slightly cheaper.
Industry RankSector Rank
PE 14.9
Fwd PE 14.02
HSII Price Earnings VS Forward Price EarningsHSII Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HSII is valued cheaply inside the industry as 93.67% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, HSII is valued cheaply inside the industry as 96.20% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.4
EV/EBITDA 4.28
HSII Per share dataHSII EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)5.16
EPS Next 2Y0.25%
EPS Next 3Y5.61%

6

5. Dividend

5.1 Amount

HSII has a Yearly Dividend Yield of 1.42%. Purely for dividend investing, there may be better candidates out there.
HSII's Dividend Yield is a higher than the industry average which is at 1.92.
HSII's Dividend Yield is slightly below the S&P500 average, which is at 2.27.
Industry RankSector Rank
Dividend Yield 1.42%

5.2 History

The dividend of HSII has a limited annual growth rate of 3.03%.
HSII has paid a dividend for at least 10 years, which is a reliable track record.
HSII has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.03%
Div Incr Years0
Div Non Decr Years11
HSII Yearly Dividends per shareHSII Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

33.06% of the earnings are spent on dividend by HSII. This is a low number and sustainable payout ratio.
The dividend of HSII is growing, but earnings are growing more, so the dividend growth is sustainable.
DP33.06%
EPS Next 2Y0.25%
EPS Next 3Y5.61%
HSII Yearly Income VS Free CF VS DividendHSII Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M
HSII Dividend Payout.HSII Dividend Payout, showing the Payout Ratio.HSII Dividend Payout.PayoutRetained Earnings

HEIDRICK & STRUGGLES INTL

NASDAQ:HSII (2/21/2025, 8:26:05 PM)

After market: 41.41 0 (0%)

41.41

-0.82 (-1.94%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)03-03 2025-03-03/amc
Inst Owners96.42%
Inst Owner Change1.43%
Ins Owners1.11%
Ins Owner Change1.48%
Market Cap845.18M
Analysts82.5
Price Target49.3 (19.05%)
Short Float %2.05%
Short Ratio3.05
Dividend
Industry RankSector Rank
Dividend Yield 1.42%
Yearly Dividend0.63
Dividend Growth(5Y)3.03%
DP33.06%
Div Incr Years0
Div Non Decr Years11
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.46%
Min EPS beat(2)4.32%
Max EPS beat(2)16.6%
EPS beat(4)4
Avg EPS beat(4)9.16%
Min EPS beat(4)1.81%
Max EPS beat(4)16.6%
EPS beat(8)7
Avg EPS beat(8)9.73%
EPS beat(12)10
Avg EPS beat(12)11.02%
EPS beat(16)14
Avg EPS beat(16)21.58%
Revenue beat(2)2
Avg Revenue beat(2)3.2%
Min Revenue beat(2)2.81%
Max Revenue beat(2)3.6%
Revenue beat(4)4
Avg Revenue beat(4)2.42%
Min Revenue beat(4)0.03%
Max Revenue beat(4)3.6%
Revenue beat(8)7
Avg Revenue beat(8)2.02%
Revenue beat(12)9
Avg Revenue beat(12)1.96%
Revenue beat(16)13
Avg Revenue beat(16)4.31%
PT rev (1m)0%
PT rev (3m)21.85%
EPS NQ rev (1m)-2.08%
EPS NQ rev (3m)-0.53%
EPS NY rev (1m)0%
EPS NY rev (3m)0.37%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)0.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.54%
Valuation
Industry RankSector Rank
PE 14.9
Fwd PE 14.02
P/S 0.77
P/FCF 8.4
P/OCF 7.41
P/B 1.75
P/tB 2.99
EV/EBITDA 4.28
EPS(TTM)2.78
EY6.71%
EPS(NY)2.95
Fwd EY7.13%
FCF(TTM)4.93
FCFY11.9%
OCF(TTM)5.59
OCFY13.49%
SpS53.51
BVpS23.68
TBVpS13.85
PEG (NY)N/A
PEG (5Y)5.16
Profitability
Industry RankSector Rank
ROA 3.37%
ROE 7.98%
ROCE 10.15%
ROIC 6.62%
ROICexc 14.56%
ROICexgc 35.34%
OM 6.98%
PM (TTM) 3.53%
GM 87.64%
FCFM 9.21%
ROA(3y)6.03%
ROA(5y)3.77%
ROE(3y)17.58%
ROE(5y)10.76%
ROIC(3y)10.58%
ROIC(5y)9.5%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.24%
ROCE(5y)14.58%
ROICexcg growth 3Y243.73%
ROICexcg growth 5YN/A
ROICexc growth 3Y-0.59%
ROICexc growth 5Y-11.51%
OM growth 3Y0.09%
OM growth 5Y-3.26%
PM growth 3YN/A
PM growth 5Y-4.85%
GM growth 3Y-3.72%
GM growth 5Y-1.96%
F-Score6
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 71.86%
Cap/Sales 1.23%
Interest Coverage 250
Cash Conversion 120.11%
Profit Quality 260.82%
Current Ratio 1.73
Quick Ratio 1.73
Altman-Z 2.53
F-Score6
WACC9.06%
ROIC/WACC0.73
Cap/Depr(3y)69.64%
Cap/Depr(5y)53.79%
Cap/Sales(3y)0.98%
Cap/Sales(5y)0.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.33%
EPS 3Y17.99%
EPS 5Y2.89%
EPS Q2Q%-1.37%
EPS Next Y-6.9%
EPS Next 2Y0.25%
EPS Next 3Y5.61%
EPS Next 5YN/A
Revenue 1Y (TTM)6.81%
Revenue growth 3Y18.27%
Revenue growth 5Y7.19%
Sales Q2Q%7.47%
Revenue Next Year6.33%
Revenue Next 2Y4.69%
Revenue Next 3Y4.32%
Revenue Next 5YN/A
EBIT growth 1Y-5.34%
EBIT growth 3Y18.37%
EBIT growth 5Y3.69%
EBIT Next Year47.68%
EBIT Next 3Y17.69%
EBIT Next 5YN/A
FCF growth 1Y-35.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.13%
OCF growth 3YN/A
OCF growth 5YN/A